NCT06866873View on ClinicalTrials.gov

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2037

Study Completion Date

December 31, 2037

Conditions
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Interventions
BIOLOGICAL

CAR-T

CAR-T cell (CHXCART01) infusion intravenously once at a dose of 0.2-2 million cells/kg recipient body weight

Trial Locations (1)

Unknown

RECRUITING

Hong Kong Children's Hospital, Hong Kong

All Listed Sponsors
lead

Hong Kong Children's Hospital

OTHER